NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases…
$2.78+2.04%
报价 2026-11-09
市值
$1.3M
EV
$982,500
PE (TTM)
8.8x
预期 PE
–
52 周区间距高点 -43.4%
$1.88$4.91
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NCELNewcelX Ltd. | $1.3M | +2.0% | – | 0% | 8.8x | – | – | |
| GOVXGeoVax Labs, Inc. | $1.4M | -9.4% | +4.0% | 0% | – | – | – | |
| ALPAlphaTON Capital Corp. Common Stock | $1.4M | +2.0% | – | 100% | – | – | – | |
| CRISCuris, Inc. | $1.4M | -23.0% | -84.3% | 99.3% | – | – | – | |
| ONCOOnconetix, Inc. | $1.3M | -48.5% | +12.5% | 80.4% | – | – | – | |
| ELABPMGC Holdings Inc. | $1.3M | -1.9% | – | 12.7% | – | – | – | |
| VBIOValion Bio, Inc. | $1.2M | +6.2% | – | 516% | – | – | – | |
| RADXRadiopharm Theranostics Limited | $1.1M | -7.7% | – | -39.4% | – | – | – | |
| NEXRNexera Technologies Ltd | $1.1M | +1.0% | – | 11.4% | – | – | – | |
| 同行中位数 | – | – | +4.0% | 46.5% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。